CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 100 of 698 entries

View as:

PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma

Phase: N/A Priority: Normal

NCT ID: NCT01220375 Org: User:

Start: 04/30/10 End: 10/31/13 Due: 10/31/14

Comparison Between Different Sampling Sites for Detection of Respiratory Viruses

Phase: N/A Priority: Normal

NCT ID: NCT06743750 Org: User:

Start: 12/19/24 End: 06/30/25 Due: 06/30/26

Myocardial Strain Analysis in Anaesthetized Coronary Artery Disease Patients During Hyperoxia and Normoxaemia

Phase: N/A Priority: Normal

NCT ID: NCT04424433 Org: User:

Start: 06/01/20 End: 06/04/21 Due: 06/04/22

Prognosis of Cerebral Small Vessel Disease

Phase: N/A Priority: Normal

NCT ID: NCT05734378 Org: User:

Start: 12/01/20 End: 11/30/30 Due: 11/30/31

Brain Circuitry Changes in Central Poststroke Pain: a Clinical and Neuroimaging Study

Phase: N/A Priority: Normal

NCT ID: NCT05335668 Org: User:

Start: 07/18/22 End: 09/30/25 Due: 09/30/26

Motives for Desiring Children in Different Sexual-romantic Orientations

Phase: N/A Priority: Normal

NCT ID: NCT05751239 Org: User:

Start: 07/03/18 End: 08/30/18 Due: 08/30/19

New Biomarkers and Difficult-to-treat Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT03034265 Org: User:

Start: 05/31/16 End: 05/31/17 Due: 05/31/18

Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19

Phase: N/A Priority: Normal

NCT ID: NCT04581135 Org: User:

Start: 05/01/20 End: 01/30/22 Due: 01/30/23

DYsphagiA in interMedIate Care UnitS

Phase: N/A Priority: Normal

NCT ID: NCT04180449 Org: User:

Start: 02/14/20 End: 12/01/24 Due: 12/01/25

Diagnostic Accuracy and Performance of 18F-PSMA-1007

Phase: N/A Priority: Normal

NCT ID: NCT04986280 Org: User:

Start: 07/13/21 End: 03/30/24 Due: 03/30/25

Effect of Permanent Internal Mammary Artery Occlusion on Extracardiac Coronary Collateral Supply

Phase: N/A Priority: Normal

NCT ID: NCT02475408 Org: User:

Start: 12/31/14 End: 04/30/16 Due: 04/30/17

eCRANIO Trial Study on Elective CRAniotomies: Postoperative Neurointensive Care, Imaging and Outcome

Phase: N/A Priority: Normal

NCT ID: NCT01987648 Org: User:

Start: 11/01/11 End: 10/31/21 Due: 10/31/22

SwissTAVI Registry

Phase: N/A Priority: Normal

NCT ID: NCT01368250 Org: User:

Start: 02/28/11 End: 05/31/25 Due: 05/31/26

Fluid Management in Patients Undergoing Cardiac Surgery

Phase: N/A Priority: Normal

NCT ID: NCT02895659 Org: User:

Start: 12/01/16 End: 10/19/17 Due: 10/19/18

Progesterone and Resting Energy Expenditure

Phase: N/A Priority: Normal

NCT ID: NCT04140968 Org: User:

Start: 11/01/19 End: 05/27/21 Due: 05/27/22

The Bern Perioperative Biobank

Phase: N/A Priority: Normal

NCT ID: NCT04767685 Org: User:

Start: 01/31/11 End: 12/31/21 Due: 12/31/22

Exercise-induced Changes in Cardiac Function & Morphology

Phase: N/A Priority: Normal

NCT ID: NCT01179802 Org: User:

Start: 07/31/10 End: 10/31/10 Due: 10/31/11

Drug-screening in AML at Relapse for Targeted Treatment

Phase: N/A Priority: Normal

NCT ID: NCT05732688 Org: User:

Start: 01/01/22 End: 07/01/24 Due: 07/01/25

Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients

Phase: N/A Priority: Normal

NCT ID: NCT01803763 Org: User:

Start: 09/30/12 End: 03/31/14 Due: 03/31/15

Surgical Pulmonary Embolectomy Versus Catheter-directed Thrombolysis in the Treatment of Pulmonary Embolism: A Non-inferiority Study

Phase: N/A Priority: Normal

NCT ID: NCT03218410 Org: User:

Start: 10/01/15 End: 12/31/20 Due: 12/31/21

Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b

Phase: N/A Priority: Normal

NCT ID: NCT00942591 Org: User:

Start: 05/31/05 End: 05/31/09 Due: 05/31/10

Transition cAre inteRvention tarGeted to High-risk patiEnts To Reduce rEADmission

Phase: N/A Priority: Normal

NCT ID: NCT03496896 Org: User:

Start: 04/03/18 End: 02/15/20 Due: 02/15/21

Longterm Functional Outcomes in Patients Undergoing Organ Preserving Treatment for Rectal Cancer With or Without Local Excision After Chemoradiotherapy

Phase: N/A Priority: Normal

NCT ID: NCT06249672 Org: User:

Start: 01/17/23 End: 12/31/34 Due: 12/31/35

Inflammatory Cardiomyopathy Bern Registry

Phase: N/A Priority: Normal

NCT ID: NCT04774549 Org: User:

Start: 01/01/05 End: 12/31/26 Due: 12/31/27

Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm

Phase: N/A Priority: Normal

NCT ID: NCT04988932 Org: User:

Start: 07/31/12 End: 03/20/20 Due: 03/20/21

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma	NCT01220375	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2010-04-30	2013-10-31	2014-10-31	-	-	2025-07-14
Comparison Between Different Sampling Sites for Detection of Respiratory Viruses	NCT06743750	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2024-12-19	2025-06-30	2026-06-30	-	-	2025-07-14
Myocardial Strain Analysis in Anaesthetized Coronary Artery Disease Patients During Hyperoxia and Normoxaemia	NCT04424433	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2020-06-01	2021-06-04	2022-06-04	-	-	2025-07-14
Prognosis of Cerebral Small Vessel Disease	NCT05734378	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2020-12-01	2030-11-30	2031-11-30	-	-	2025-07-14
Brain Circuitry Changes in Central Poststroke Pain: a Clinical and Neuroimaging Study	NCT05335668	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2022-07-18	2025-09-30	2026-09-30	-	-	2025-07-14
Motives for Desiring Children in Different Sexual-romantic Orientations	NCT05751239	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2018-07-03	2018-08-30	2019-08-30	-	-	2025-07-14
New Biomarkers and Difficult-to-treat Hypertension	NCT03034265	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2016-05-31	2017-05-31	2018-05-31	-	-	2025-07-14
Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19	NCT04581135	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2020-05-01	2022-01-30	2023-01-30	-	-	2025-07-14
DYsphagiA in interMedIate Care UnitS	NCT04180449	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2020-02-14	2024-12-01	2025-12-01	-	-	2025-07-14
Diagnostic Accuracy and Performance of 18F-PSMA-1007	NCT04986280	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2021-07-13	2024-03-30	2025-03-30	-	-	2025-07-14
Effect of Permanent Internal Mammary Artery Occlusion on Extracardiac Coronary Collateral Supply	NCT02475408	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2014-12-31	2016-04-30	2017-04-30	-	-	2025-07-14
eCRANIO Trial Study on Elective CRAniotomies: Postoperative Neurointensive Care, Imaging and Outcome	NCT01987648	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2011-11-01	2021-10-31	2022-10-31	-	-	2025-07-14
SwissTAVI Registry	NCT01368250	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2011-02-28	2025-05-31	2026-05-31	-	-	2025-07-14
Fluid Management in Patients Undergoing Cardiac Surgery	NCT02895659	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2016-12-01	2017-10-19	2018-10-19	-	-	2025-07-14
Progesterone and Resting Energy Expenditure	NCT04140968	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2019-11-01	2021-05-27	2022-05-27	-	-	2025-07-14
The Bern Perioperative Biobank	NCT04767685	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2011-01-31	2021-12-31	2022-12-31	-	-	2025-07-14
Exercise-induced Changes in Cardiac Function & Morphology	NCT01179802	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2010-07-31	2010-10-31	2011-10-31	-	-	2025-07-14
Drug-screening in AML at Relapse for Targeted Treatment	NCT05732688	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2022-01-01	2024-07-01	2025-07-01	-	-	2025-07-14
Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients	NCT01803763	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2012-09-30	2014-03-31	2015-03-31	-	-	2025-07-14
Surgical Pulmonary Embolectomy Versus Catheter-directed Thrombolysis in the Treatment of Pulmonary Embolism: A Non-inferiority Study	NCT03218410	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2015-10-01	2020-12-31	2021-12-31	-	-	2025-07-14
Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b	NCT00942591	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2005-05-31	2009-05-31	2010-05-31	-	-	2025-07-14
Transition cAre inteRvention tarGeted to High-risk patiEnts To Reduce rEADmission	NCT03496896	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2018-04-03	2020-02-15	2021-02-15	-	-	2025-07-14
Longterm Functional Outcomes in Patients Undergoing Organ Preserving Treatment for Rectal Cancer With or Without Local Excision After Chemoradiotherapy	NCT06249672	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2023-01-17	2034-12-31	2035-12-31	-	-	2025-07-14
Inflammatory Cardiomyopathy Bern Registry	NCT04774549	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2005-01-01	2026-12-31	2027-12-31	-	-	2025-07-14
Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm	NCT04988932	Insel Gruppe AG, University Hospital Bern	user2@example.com	None	2012-07-31	2020-03-20	2021-03-20	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance